Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant
Neven, P, Fasching, P. A, Chia, S, Jerusalem, G, De Laurentiis, M, Im, S.-A, Petrakova, K, Bianchi, G. V, Martín, M, Nusch, A, Sonke, G. S, De la Cruz-Merino, L, Beck, J. T, Zarate, J. P, Wang, Y, Chakravartty, A, Wang, C, Slamon, D. J
Published in Breast cancer research : BCR (31.08.2023)
Published in Breast cancer research : BCR (31.08.2023)
Get full text
Journal Article
Web Resource
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
GERBER, B, LOIBL, S, KREIENBERG, R, SOLBACH, C, JACKISCH, C, KUNZ, G, BLOHMER, J. U, HUOBER, J, HAUSCHILD, M, NEKLJUDOVA, V, UNTCH, M, VON MINCKWITZ, G, EIDTMANN, H, REZAI, M, FASCHING, P. A, TESCH, H, EGGEMANN, H, SCHRADER, I, KITTEL, K, HANUSCH, C
Published in Annals of oncology (01.12.2013)
Published in Annals of oncology (01.12.2013)
Get full text
Journal Article
Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study
Curigliano, G., Dunton, K., Rosenlund, M., Janek, M., Cathcart, J., Liu, Y., Fasching, P.A., Iwata, H.
Published in Annals of oncology (01.07.2023)
Published in Annals of oncology (01.07.2023)
Get full text
Journal Article
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma
Mürdter, T E, Schroth, W, Bacchus-Gerybadze, L, Winter, S, Heinkele, G, Simon, W, Fasching, P A, Fehm, T, Eichelbaum, M, Schwab, M, Brauch, H
Published in Clinical pharmacology and therapeutics (01.05.2011)
Published in Clinical pharmacology and therapeutics (01.05.2011)
Get more information
Journal Article
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
WISHART, G. C, BAJDIK, C. D, OLSON, J. E, BECKMANN, M. W, WINQVIST, R, CROSS, S. S, SEVERI, G, HUNTSMAN, D, PYLKÄS, K, ELLIS, I, NIELSEN, T. O, GILES, G, DICKS, E, BLOMQVIST, C, FASCHING, P. A, COUCH, F. J, RAKHA, E, FOULKES, W. D, BLOWS, F. M, BEGIN, L. R, VEER, Lj Van't, SOUTHEY, M, NEVANLINNA, H, PROVENZANO, E, MANNERMAA, A, COX, A, CHEANG, M, BAGLIETTO, L, CALDAS, C, GARCIA-CLOSAS, M, PHAROAH, Pdp, SCHMIDT, M. K, SHERMAN, M, GREENBERG, D. C, GREEN, A. R, GELMON, K. A, KOSMA, V.-M
Published in British journal of cancer (21.08.2012)
Published in British journal of cancer (21.08.2012)
Get full text
Journal Article
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry
Witzel, I., Laakmann, E., Weide, R., Neunhöffer, T., Park-Simon, T.-J., Schmidt, M., Fasching, P.A., Hesse, T., Polasik, A., Mohrmann, S., Würschmidt, F., Schem, C., Bechtner, C., Würstlein, R., Fehm, T., Möbus, V., Burchardi, N., Loibl, S., Müller, V.
Published in European journal of cancer (1990) (01.10.2018)
Published in European journal of cancer (1990) (01.10.2018)
Get full text
Journal Article
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
Pusztai, L., Denkert, C., O’Shaughnessy, J., Cortes, J., Dent, R., McArthur, H., Kümmel, S., Bergh, J., Park, Y.H., Hui, R., Harbeck, N., Takahashi, M., Untch, M., Fasching, P.A., Cardoso, F., Zhu, Y., Pan, W., Tryfonidis, K., Schmid, P.
Published in Annals of oncology (01.05.2024)
Published in Annals of oncology (01.05.2024)
Get full text
Journal Article
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin–cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer—outcome on prognosis
Untch, M., von Minckwitz, G., Konecny, G.E., Conrad, U., Fett, W., Kurzeder, C., Lück, H.-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Beckmann, M.W., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Nekljudova, V., Lebeau, A., Loibl, S., Fasching, P.A.
Published in Annals of oncology (01.09.2011)
Published in Annals of oncology (01.09.2011)
Get full text
Journal Article
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel±darbepoetin alfa in primary breast cancer—results at the time of surgery
Untch, M., Fasching, P.A., Konecny, G.E., von Koch, F., Conrad, U., Fett, W., Kurzeder, C., Lück, H.-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Schuster, T., Nekljudova, V., Lebeau, A., Loibl, S., von Minckwitz, G.
Published in Annals of oncology (01.09.2011)
Published in Annals of oncology (01.09.2011)
Get full text
Journal Article
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)
von Minckwitz, G., Rezai, M., Fasching, P.A., Huober, J., Tesch, H., Bauerfeind, I., Hilfrich, J., Eidtmann, H., Gerber, B., Hanusch, C., Blohmer, J.U., Costa, S.D., Jackisch, C., Paepke, S., Schneeweiss, A., Kümmel, S., Denkert, C., Mehta, K., Loibl, S., Untch, M.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics
Poehls, U G, Hack, C C, Ekici, A B, Beckmann, M W, Fasching, P A, Ruebner, M, Huebner, H
Published in European journal of medical research (27.04.2018)
Published in European journal of medical research (27.04.2018)
Get full text
Journal Article
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study
Higgins, M., Curigliano, G., Dieras, V., Kuemmel, S., Kunz, G., Fasching, P. A., Campone, M., Bachelot, T., Krivorotko, P., Chan, S., Ferro, A., Schwartzberg, L., Gillet, M., De Sousa Alves, P. M., Wascotte, V., Lehmann, F. F., Goss, P.
Published in Breast cancer research and treatment (01.04.2017)
Published in Breast cancer research and treatment (01.04.2017)
Get full text
Journal Article
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial
von Minckwitz, G., Eidtmann, H., Loibl, S., Blohmer, J.-U., Costa, S.-D., Fasching, P.A., Kreienberg, R., Hilfrich, J., Gerber, B., Hanusch, C., Fehm, T., Strumberg, D., Solbach, C., Nekljudova, V., Untch, M.
Published in Annals of oncology (01.02.2011)
Published in Annals of oncology (01.02.2011)
Get full text
Journal Article
Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial
Hurvitz, S.A., Quek, R.G.W., Turner, N.C., Telli, M.L., Rugo, H.S., Mailliez, A., Ettl, J., Grischke, E., Mina, L.A., Balmaña, J., Fasching, P.A., Bhattacharyya, H., Hannah, A.L., Robson, M.E., Wardley, A.M.
Published in European journal of cancer (1990) (01.11.2018)
Published in European journal of cancer (1990) (01.11.2018)
Get full text
Journal Article
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab: a translational project in the neoadjuvant GeparQuinto trial
WITZEL, I, LOIBL, S, MAU, C, SCHEM, C, RACK, B, MEINHOLD-HEERLEIN, I, LIEDTKE, C, KARN, T, HUOBER, J, ZU EULENBURG, C, ISSA-NUMMER, Y, UNTCH, M, MINCKWITZ, G. Von, MÜLLER, V, EIDTMANN, H, FEHM, T, KHANDAN, F, SCHMATLOCH, S, HAUSCHILD, M, BISCHOFF, J, FASCHING, P. A
Published in British journal of cancer (04.09.2012)
Published in British journal of cancer (04.09.2012)
Get full text
Journal Article
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
Loibl, S., Untch, M., Burchardi, N., Huober, J., Sinn, B.V., Blohmer, J.-U., Grischke, E.-M., Furlanetto, J., Tesch, H., Hanusch, C., Engels, K., Rezai, M., Jackisch, C., Schmitt, W.D., von Minckwitz, G., Thomalla, J., Kümmel, S., Rautenberg, B., Fasching, P.A., Weber, K., Rhiem, K., Denkert, C., Schneeweiss, A.
Published in Annals of oncology (01.08.2019)
Published in Annals of oncology (01.08.2019)
Get full text
Journal Article
Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy
Fasching, P. A., Kollmannsberger, B., Strissel, P. L., Niesler, B., Engel, J., Kreis, H., Lux, M. P., Weihbrecht, S., Lausen, B., Bani, M. R., Beckmann, M. W., Strick, R.
Published in Journal of cancer research and clinical oncology (01.10.2008)
Published in Journal of cancer research and clinical oncology (01.10.2008)
Get full text
Journal Article
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
Slamon, D.J., Neven, P., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S., Petrakova, K., Valeria Bianchi, G., Martín, M., Nusch, A., Sonke, G.S., De la Cruz-Merino, L., Beck, J.T., Ji, Y., Wang, C., Deore, U., Chakravartty, A., Zarate, J.P., Taran, T., Fasching, P.A.
Published in Annals of oncology (01.08.2021)
Published in Annals of oncology (01.08.2021)
Get full text
Journal Article
Web Resource
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
Loibl, S., Schneeweiss, A., Huober, J., Braun, M., Rey, J., Blohmer, J.-U., Furlanetto, J., Zahm, D.-M., Hanusch, C., Thomalla, J., Jackisch, C., Staib, P., Link, T., Rhiem, K., Solbach, C., Fasching, P.A., Nekljudova, V., Denkert, C., Untch, M.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself
HEUSINGER, K, LÖHBERG, C, LUX, M. P, PAPADOPOULOS, T, IMHOFF, K, SCHULZ-WENDTLAND, R, BECKMANN, M. W, FASCHING, P. A
Published in Breast cancer research and treatment (01.11.2005)
Published in Breast cancer research and treatment (01.11.2005)
Get full text
Journal Article